Skip to content

Clinical trial of insoles for heel pain

A randomized controlled trial to evaluate the effectiveness of insoles to treat plantar heel pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN47272667
Enrollment
150
Registered
2008-07-31
Start date
2008-03-28
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar heel pain Musculoskeletal Diseases Plantar heel pain

Interventions

The participants will be randomly allocated to the following three arms: 1. Intervention group 1: Orthaheel® regular. This is a 3/4 length insole with arch shape which is positioned under the heel a

Sponsors

SSL International (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female participants between the ages of 18 and 65 years old 2. Participants with self-reported plantar heel pain with a minimum of 4 weeks duration 3. Self-reported plantar heel pain who score at least 40 mm on a 100 mm visual analogue scale (VAS) for pain 4. Participants with plantar heel pain in the 2 days prior to recruitment 5. Participants who agree to wear the insoles provided for at least 4 hours each day 6. Participants who give written informed consent

Exclusion criteria

Exclusion criteria: 1. Participants reporting acute injury to the foot at the onset of the plantar heel pain 2. Participants with posterior or medial/lateral heel pain or any secondary pain elsewhere in the foot since the onset of plantar heel pain 3. Participants with significant musculo-skeletal disease diagnosed such as rheumatoid arthritis, hip, knee or back pain 4. Participants with sensory or motor function disease such as diabetes 5. Participants who are pregnant or breast-feeding 6. Participants who have received or self-administered treatment for the heel pain in the previous 4 weeks 7. Participants who have received corticosteroid injection therapy in the heel in the previous 3 months 8. Participants that were previously in this study 9. Participants that were in another study within the last 3 months

Design outcomes

Primary

MeasureTime frame
1. Foot pain 2. Foot health related function Foot pain will be measured primarily using a 0-10 visual analogue scale. The Foot Health Status Questionnaire (FHSQ) will be used to provide categorical assessment of pain and foot health related function. Primary timepoint of interest: 4 weeks

Secondary

MeasureTime frame
1. Use of insoles (in time) 2. Foot pain at 3, 6 and 12 months (see Primary outcome measures for details) 3. Foot health related function at 3, 6 and 12 months (see Primary outcome measures for details)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026